Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:35 UTC |
---|
HMDB ID | HMDB0014365 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nelfinavir |
---|
Description | Nelfinavir, also known as viracept or 1UN, belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Nelfinavir is a drug which is used in combination with other antiviral drugs in the treatment of hiv in both adults and children. Nelfinavir is a very strong basic compound (based on its pKa). An aryl sulfide that is used (as its mesylate salt) for treatment of HIV and also exhibits some anticancer properties. |
---|
Structure | [H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Viracept | Kegg | 1UN | HMDB | AG1343 | HMDB | NFV | HMDB | NLF | HMDB | Mesylate, nelfinavir | HMDB | Nelfinavir mesylate | HMDB | Roche brand OF nelfinavir mesylate | HMDB | Agouron brand OF nelfinavir mesylate | HMDB | Monomethane sulfonate, nelfinavir | HMDB | Nelfinavir monomethane sulfonate | HMDB | Sulfonate, nelfinavir monomethane | HMDB |
|
---|
Chemical Formula | C32H45N3O4S |
---|
Average Molecular Weight | 567.782 |
---|
Monoisotopic Molecular Weight | 567.313077633 |
---|
IUPAC Name | (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide |
---|
Traditional Name | nelfinavir |
---|
CAS Registry Number | 159989-64-7 |
---|
SMILES | [H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C |
---|
InChI Identifier | InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1 |
---|
InChI Key | QAGYKUNXZHXKMR-HKWSIXNMSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- Alpha-amino acid
- Tricarboxylic acid or derivatives
- Carboxamide group
- Carboxylic acid salt
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Amino acid
- Carboxylic acid
- Carbonyl group
- Amine
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic zwitterion
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 349.84 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0019 g/L | Not Available | LogP | 6 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Nelfinavir,1TMS,isomer #1 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C | 4363.8 | Semi standard non polar | 33892256 | Nelfinavir,1TMS,isomer #2 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C | 4413.7 | Semi standard non polar | 33892256 | Nelfinavir,1TMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)[Si](C)(C)C | 4264.6 | Semi standard non polar | 33892256 | Nelfinavir,1TMS,isomer #4 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C | 4313.5 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C | 4355.6 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #2 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4210.0 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C | 4263.6 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #4 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)[Si](C)(C)C | 4242.4 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #5 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C | 4323.8 | Semi standard non polar | 33892256 | Nelfinavir,2TMS,isomer #6 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4230.6 | Semi standard non polar | 33892256 | Nelfinavir,3TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4232.5 | Semi standard non polar | 33892256 | Nelfinavir,3TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 3888.2 | Standard non polar | 33892256 | Nelfinavir,3TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 5285.2 | Standard polar | 33892256 | Nelfinavir,3TMS,isomer #2 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C | 4322.1 | Semi standard non polar | 33892256 | Nelfinavir,3TMS,isomer #2 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C | 4105.9 | Standard non polar | 33892256 | Nelfinavir,3TMS,isomer #2 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C | 5265.0 | Standard polar | 33892256 | Nelfinavir,3TMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4219.8 | Semi standard non polar | 33892256 | Nelfinavir,3TMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4040.2 | Standard non polar | 33892256 | Nelfinavir,3TMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 5355.7 | Standard polar | 33892256 | Nelfinavir,3TMS,isomer #4 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4228.2 | Semi standard non polar | 33892256 | Nelfinavir,3TMS,isomer #4 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 3993.8 | Standard non polar | 33892256 | Nelfinavir,3TMS,isomer #4 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 5331.5 | Standard polar | 33892256 | Nelfinavir,4TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4257.0 | Semi standard non polar | 33892256 | Nelfinavir,4TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4003.6 | Standard non polar | 33892256 | Nelfinavir,4TMS,isomer #1 | CC1=C(O[Si](C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 5017.2 | Standard polar | 33892256 | Nelfinavir,1TBDMS,isomer #1 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C(C)(C)C | 4584.4 | Semi standard non polar | 33892256 | Nelfinavir,1TBDMS,isomer #2 | CC1=C(O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C | 4637.7 | Semi standard non polar | 33892256 | Nelfinavir,1TBDMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)[Si](C)(C)C(C)(C)C | 4509.4 | Semi standard non polar | 33892256 | Nelfinavir,1TBDMS,isomer #4 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C(C)(C)C | 4551.7 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #1 | CC1=C(O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C(C)(C)C | 4740.4 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #2 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4619.6 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #3 | CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@@H](CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4704.8 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #4 | CC1=C(O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)[Si](C)(C)C(C)(C)C | 4655.4 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #5 | CC1=C(O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C(C)(C)C | 4740.4 | Semi standard non polar | 33892256 | Nelfinavir,2TBDMS,isomer #6 | CC1=C(O)C=CC=C1C(=O)N([C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)N(C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4677.1 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zfr-4920620000-3e97d75bc5482ebe0292 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (1 TMS) - 70eV, Positive | splash10-0kg9-8911174000-b5a95eb726f2120de44f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS ("Nelfinavir,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nelfinavir GC-MS (TBDMS_2_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Nelfinavir 35V, Positive-QTOF | splash10-0159-0108790000-37fcb21172a9ab3929df | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nelfinavir 35V, Negative-QTOF | splash10-066r-0500490000-2b60cc13f05a81cee051 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 10V, Positive-QTOF | splash10-0uxr-0200690000-77a23536b639a89f4cd8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 20V, Positive-QTOF | splash10-05mt-0901820000-013b242385d051fde141 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 40V, Positive-QTOF | splash10-0a4i-2902300000-292089c6320aca2e4bf3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 10V, Negative-QTOF | splash10-066r-1720190000-ff4bf8c8c081b81f42e8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 20V, Negative-QTOF | splash10-0a4i-1900100000-c01f4e3e23817695f9f5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 40V, Negative-QTOF | splash10-0a4i-3931000000-f277385d71a7ecbd185d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 10V, Positive-QTOF | splash10-014i-0000290000-808f2745b90a26e169ea | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 20V, Positive-QTOF | splash10-014i-0302980000-8e50db73432875fa39a8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 40V, Positive-QTOF | splash10-0cdi-2902000000-b9e590ecbc4e167172f7 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 10V, Negative-QTOF | splash10-0aor-0200950000-d9742f312986b0024312 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 20V, Negative-QTOF | splash10-0a4i-0900000000-48e1526dd8ca736a1ffc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nelfinavir 40V, Negative-QTOF | splash10-0a4i-2903000000-de4b527f793c0b85d54b | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
General References | - Kaldor SW, Kalish VJ, Davies JF 2nd, Shetty BV, Fritz JE, Appelt K, Burgess JA, Campanale KM, Chirgadze NY, Clawson DK, Dressman BA, Hatch SD, Khalil DA, Kosa MB, Lubbehusen PP, Muesing MA, Patick AK, Reich SH, Su KS, Tatlock JH: Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem. 1997 Nov 21;40(24):3979-85. [PubMed:9397180 ]
|
---|